Showing 1 - 3 of 3
Protecting Thailand’s Youngest and Oldest from RSV, Flu
Published on 07/07/2025
» Bangkok, July 7, 2025 — As Thailand transitions from the rainy to early winter seasons, respiratory infections surge dramatically, making awareness and proper prevention crucial. Recognising this urgent public health concern, Sanofi Thailand supported a vital Health Talk session at Thailand Healthcare 2025 under the topic: "Infants Catch It Easily, the Elderly are at High Risk: Understanding RSV and Influenza." The session featured distinguished medical experts Prof. Dr. Sasisopin Kiertiburanakul and Assoc. Prof. Dr. Sophida Boonsathorn Reeves, infectious disease specialists from the Faculty of Medicine, Ramathibodi Hospital, Mahidol University. They shared comprehensive knowledge and strategic prevention approaches to protect families, with particular focus on the most vulnerable groups: newborns, infants, and seniors aged 65 and above.
Sanofi Leads Regional Effort to Safeguard Flu Vulnerable
Published on 20/05/2025
» Bangkok, Thailand – Sanofi, a global leader in biopharmaceutical innovation, recently hosted a hybrid symposium titled "Safeguarding High-Risk Groups: The Importance of Flu Prevention and Effective Communication." The event brought together 380 healthcare professionals from across Southeast Asia and India to address the burden of influenza among vulnerable populations and shared strategies for improving health outcomes.
Experts Suggested Elevating Elderly Care with “Protection Beyond Flu”
Published on 12/12/2024
» · Research in Denmark* reveals that the elderly protection with High-Dose Influenza Vaccine could reduce flu and pneumonia hospitalizations by 64.4% and lower mortality rates by 48.9%